Kolon Life Science Inc. (102940.KQ)
KRW 22850.0
(0.22%)
KRW 22850.0
(0.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 124.63 Billion | 161.58 Billion | 165.48 Billion | 129.41 Billion | 148.54 Billion |
| Cost of Revenue | 112.22 Billion | 124.44 Billion | 128.28 Billion | 110.51 Billion | 123.17 Billion |
| Gross Profit | 12.41 Billion | 37.13 Billion | 37.2 Billion | 18.89 Billion | 25.36 Billion |
| Operating Expenses | 36.5 Billion | 26.9 Billion | 28.98 Billion | 58.33 Billion | 102.27 Billion |
| Selling, General and Administrative Expenses | 11.46 Billion | 11.75 Billion | 10.6 Billion | 17.63 Billion | 30.45 Billion |
| Research and Development Expenses | 14.89 Billion | 13.58 Billion | 14.32 Billion | 13.15 Billion | 18.49 Billion |
| Other Expenses | 10.15 Billion | 8.09 Billion | 2.01 Billion | 2.5 Billion | - |
| Cost and Expenses | 148.73 Billion | 151.34 Billion | 157.26 Billion | 168.85 Billion | 225.45 Billion |
| Operating Income | -24.09 Billion | 2.64 Billion | 3.87 Billion | -25.83 Billion | -26.54 Billion |
| Interest Expense | 5.85 Billion | 3.72 Billion | 6.01 Billion | 5.51 Billion | 3.74 Billion |
| Income Tax Expense | 1.25 Million | 107.92 Million | -2.63 Billion | -14.73 Billion | 12.12 Billion |
| Earnings before Tax | -33.59 Billion | 4.12 Billion | -4.01 Billion | -43.19 Billion | -80.19 Billion |
| Net Income | -30.72 Billion | 2.13 Billion | -1.37 Billion | -43.19 Billion | -92.32 Billion |
| Earnings Per Share Basic | -2692.00 | 187.00 | -121.00 | -3789.00 | -8098.00 |
| Earnings Per Share Diluted | -2431.00 | 163.00 | -121.00 | -3789.00 | -8098.00 |
| Weighted Average Shares Outstanding | 11.41 Million | 11.4 Million | 11.36 Million | 11.4 Million | 11.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.63 Million | 13.08 Million | 11.36 Million | 11.4 Million | 11.4 Million |
| Gross Margin | 0.10 | 0.23 | 0.22 | 0.15 | 0.17 |
| EBIT Margin | -0.13 | 0.12 | 0.11 | -0.21 | -0.08 |
| Profit Margin | -0.25 | 0.01 | -0.01 | -0.33 | -0.62 |
| EBITDA | -15.75 Billion | 12.1 Billion | 15.54 Billion | -24.64 Billion | -12.5 Billion |
| Earnings Before Tax Margin | -0.19 | 0.02 | 0.02 | -0.20 | -0.18 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 40.04 Billion | 38.55 Billion | 33.45 Billion | 124.63 Billion | 28.21 Billion | 31.59 Billion |
| Cost of Revenue | 36.72 Billion | 33.09 Billion | 32.29 Billion | 112.22 Billion | 24.8 Billion | 27.19 Billion |
| Gross Profit | 3.32 Billion | 5.46 Billion | 1.16 Billion | 12.41 Billion | 3.41 Billion | 4.39 Billion |
| Operating Expenses | -9.73 Billion | -8.93 Billion | 9.48 Billion | 36.54 Billion | 8.97 Billion | 8.6 Billion |
| Selling, General and Administrative Expenses | 9.73 Billion | 8.93 Billion | 2.94 Billion | - | 2.75 Billion | 2.91 Billion |
| Research and Development Expenses | 4.83 Billion | 3.82 Billion | 3.59 Billion | - | 3.94 Billion | 3.6 Billion |
| Other Expenses | -19.47 Billion | -17.87 Billion | -89.14 Million | 90.87 Million | -5.44 Million | 255.03 Million |
| Cost and Expenses | 36.72 Billion | 33.09 Billion | 41.77 Billion | 148.77 Billion | 33.77 Billion | 35.8 Billion |
| Operating Income | -6.41 Billion | -3.47 Billion | -8.2 Billion | -24.09 Billion | -5.7 Billion | -4.47 Billion |
| Interest Expense | - | 1.78 Billion | 1.65 Billion | 5.85 Billion | 1.67 Billion | 1.36 Billion |
| Income Tax Expense | - | - | -30.14 Million | 1.25 Million | 363.68 Million | -113.99 Million |
| Earnings before Tax | -59.31 Billion | -4.54 Billion | -13.39 Billion | -33.59 Billion | -7.01 Billion | -5.8 Billion |
| Net Income | -59.31 Billion | -4.54 Billion | -13.41 Billion | -30.72 Billion | -7.01 Billion | -5.63 Billion |
| Earnings Per Share Basic | -4809.83 | -398.00 | -1175.48 | - | -614.70 | -493.78 |
| Earnings Per Share Diluted | -4809.83 | -398.00 | -1115.59 | - | -614.70 | -493.78 |
| Weighted Average Shares Outstanding | 12.33 Million | 11.41 Million | 11.41 Million | 11.41 Million | 11.41 Million | 11.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.33 Million | 11.41 Million | 12.02 Million | 12.63 Million | 11.41 Million | 11.41 Million |
| Gross Margin | 0.08 | 0.14 | 0.03 | 0.10 | 0.12 | 0.14 |
| EBIT Margin | 0.08 | 0.14 | -0.19 | - | -0.11 | -0.07 |
| Profit Margin | -1.48 | -0.12 | -0.40 | -0.25 | -0.25 | -0.18 |
| EBITDA | 3.32 Billion | 5.46 Billion | -6.44 Billion | - | -3.2 Billion | -2.14 Billion |
| Earnings Before Tax Margin | -0.16 | -0.09 | -0.25 | -0.19 | -0.20 | -0.14 |
IART
CPAC
4378
TLIS
9969
0623